Management of COPD in Asia: A position statement of the Asian Pacific Society of Respirology

on behalf the COPD Assembly of the APSR

Research output: Contribution to journalReview articlepeer-review

27 Citations (Scopus)


Chronic obstructive pulmonary disease (COPD) is a major disease in Asia. However, how to manage specifically Asian COPD patients has not been proposed. Awareness of COPD is very low and underdiagnosis/undertreatment is common in Asian countries. Low utilization of pulmonary function test and inhalers is also a problem. Moreover, high smoking prevalence and air pollution are barriers to managing Asian patients with COPD. The relatively low body mass index of Asian patients with COPD can increase their risk for experiencing adverse effects from COPD drugs. Physicians should consider the unique features of Asian populations with COPD such as the high prevalence rates of bronchiectasis and tuberculosis-destroyed lungs, biomass smoke exposure and parasitic infection.

Original languageEnglish
Pages (from-to)1018-1025
Number of pages8
Issue number10
Publication statusPublished - 1 Jan 2019


  • air pollution
  • bronchiectasis
  • chronic obstructive pulmonary disease
  • tuberculosis


Dive into the research topics of 'Management of COPD in Asia: A position statement of the Asian Pacific Society of Respirology'. Together they form a unique fingerprint.

Cite this